Armata Pharmaceuticals, Inc.
ARMP
$9.00
$0.182.04%
AMEX
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -6.38% | -46.57% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -6.38% | -46.57% | |||
| Cost of Revenue | -133.14% | 3,387.43% | |||
| Gross Profit | 164.63% | -333.02% | |||
| SG&A Expenses | 267.28% | 18.79% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 6.28% | -0.87% | |||
| Operating Income | -8.17% | -13.62% | |||
| Income Before Tax | -365.97% | -63.70% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -365.97% | -63.70% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -365.97% | -63.70% | |||
| EBIT | -8.17% | -13.62% | |||
| EBITDA | -7.93% | -14.33% | |||
| EPS Basic | -364.39% | -63.55% | |||
| Normalized Basic EPS | -8.62% | -14.00% | |||
| EPS Diluted | -364.95% | -63.55% | |||
| Normalized Diluted EPS | -8.62% | -14.00% | |||
| Average Basic Shares Outstanding | 0.35% | 0.09% | |||
| Average Diluted Shares Outstanding | 0.35% | 0.09% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||